Showing results (721-730 of 834) with videos related to

Sort By:
Pageof 84
Archives of General Psychiatry|July 30, 2003
Consensus statement on the upcoming crisis in geriatric mental health: research agenda for the next 2 decadesD V Jeste, G S Alexopoulos, S J Bartels, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 4, 2010
Hippocampal, caudate, and ventricular changes in Parkinson's disease with and without dementiaLiana G Apostolova, Mona Beyer, Amity E Green, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 14, 2023
Neoadjuvant Targeted Therapy in Resectable NSCLC: Current and Future PerspectivesJay M Lee, Ciaran J McNamee, Eric Toloza, et al.
Molecular Psychiatry|August 30, 2021
The Amyloid-β Pathway in Alzheimer's DiseaseHarald Hampel, John Hardy, Kaj Blennow, et al.
Archives of Neurology|May 21, 2003
Novel tau polymorphisms, tau haplotypes, and splicing in familial and sporadic frontotemporal dementiaMaria-Jesús Sobrido, Bruce L Miller, Necat Havlioglu, et al.
The Journal of Prevention of Alzheimer'S Disease|May 11, 2022
Dual Task Performance Is Associated with Amyloidosis in Cognitively Healthy AdultsJ K Longhurst, J L Cummings, S E John, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 1, 2019
Gut Resistome After Oral Antibiotics in Preschool Children in Burkina Faso: A Randomized, Controlled TrialCatherine E Oldenburg, Armin Hinterwirth, Ali Sié, et al.
Archives of General Psychiatry|October 4, 2000
Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: a double-blind, randomized, placebo-controlled trial. The HGEU Study GroupJ S Street, W S Clark, K S Gannon, et al.
The New England Journal of Medicine|May 3, 2018
Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer's DiseaseMichael F Egan, James Kost, Pierre N Tariot, et al.
Bioorganic & Medicinal Chemistry Letters|April 11, 2008
Selective androgen receptor modulators based on a series of 7H-[1,4]oxazino[3,2-g]quinolin-7-ones with improved in vivo activityYun Oliver Long, Robert I Higuchi, Thomas R Caferro, et al.
Pageof 84